Page 36

Our Researchers Study of the Roles and Mechanisms of PINK1 and Parkin in Mitophagy Paul Lebot, mentor Serge Przedborski, M.D., Ph.D., Columbia University Medical Center

Dissecting the Role of c-Abl in Parkinson's Andi Shahu, mentor Ted Dawson, M.D., Ph.D., Johns Hopkins University School of Medicine Neuropsychological Predictors of Disease

The Molecular Interaction of Non-catechol Drugs with Dopamine D1 Receptors: Towards Improved Therapy for Parkinson’s Disease Sang Min Lee, mentor Richard Mailman, Ph.D., The Pennsylvania State University College of Medicine

Progression in Early Onset Parkinson’s Disease Megha Subramanian, mentor Paul J. Eslinger, Ph.D., The Pennsylvania State University College of Medicine

Effects of Alpha-synuclein Immunotherapy in a Mouse Model of Parkinson's Disease Eric Lin, mentor Virginia M.-Y. Lee, Ph.D., Perelman School of Medicine at the University of Pennsylvania

The Effect of Unilateral vs. Bilateral Deep Brain Stimulation of the Subthalamic Nucleus on Memory-Guided Sequential Pointing Ruth Tangonan, mentor Daniel Corcos, Ph.D., University of Illinois at Chicago

Using Drosophila to Investigate the Synaptic Effects of Ziram, a Parkinson’s Disease-Linked Pesticide Ciara Martin, mentor David Krantz, M.D., Ph.D., University of California, Los Angeles

Comparison of a Bimanual and Unimanual Finger Tapping Test for Detection of Upper-Limb Movement Variability and Freezing Episodes in Parkinson's Megan Trager, mentor Helen Bronte-Stewart, M.D., M.S.E., Stanford University

Interactions Between Tyrosine Hydroxylase and 14-3-3 Protein Ewa Nowara, mentor S. Colette Daubner, Ph.D., University of Texas Health Science Center at San Antonio

The Characterization of Autophagy in MPP+-induced Dopaminergic Cells Eric Tsai, mentor Karen O'Malley, Ph.D., Washington University School of Medicine in St. Louis

Rescue of Tyrosine Hydroxylase by Soluble GFR Alpha-1 in 6-OHDA Parkinson’s Model Catherine Owens, mentor Michael Salvatore, Ph.D., Louisiana State University Health Sciences Center Shreveport

Molecular Mechanisms by Which Excess Synuclein Impairs Synapse Function: Implications for Parkinson’s Alexandra van Brummen, mentor Jennifer Morgan, Ph.D., The University of Texas at Austin

Mild Cognitive Impairment and Health-Related Quality of Life in Non-demented Parkinson's Disease Patients William Reginold, mentor Connie Marras, M.D., Ph.D., Toronto Western Hospital Comparing Diagnostic Criteria of Mild Cognitive Impairment over Three Year Follow-up in People with Parkinson’s Disease without Dementia William Reginold, mentor Connie Marras, M.D., Ph.D., Toronto Western Hospital The Utilization of Mobile Technology for the Optimization of Deep Brain Stimulation Parameters for the Treatment of Postural Stability Sarah Richardson, mentor Jay Alberts, Ph.D., Cleveland Clinic

Phenotype-Specific Cell Loss in the Human Olfactory Bulb Associated with Parkinson’s Disease Ava Weibman, mentor John Cave, Ph.D., Burke Medical Research Institute Protection of Dissociated Rat Substantia Nigra Cultures from MPP+ Toxicity by a Combination of Neurotrophic Factors Stephanie Wyrostek, mentor Michael J. Zigmond, Ph.D., University of Pittsburgh Evaluation of Peripheral Olfactory Adaptation as a Potential Biomarker for Parkinson’s Disease Wendy Yoder, mentor David Smith, Ph.D., University of Florida

Impact: Biennial Report 2012-2013 | 36

Impact: Parkinson’s Disease Foundation Biennial Report 2012-2013  

How is the Parkinson’s Disease Foundation (PDF) making an impact? Browse this report for the answers. Learn about our programs of research,...

Impact: Parkinson’s Disease Foundation Biennial Report 2012-2013  

How is the Parkinson’s Disease Foundation (PDF) making an impact? Browse this report for the answers. Learn about our programs of research,...

Advertisement